JENNIFER LAUREN BROAD M.D.
Prescription History 1801039821
Obstetrics & Gynecology in Costa Mesa, CA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for JENNIFER LAUREN BROAD M.D., an active Obstetrics & Gynecology specialist practicing in Costa Mesa, CA. Our medical registry currently tracks 8 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 179 documented patient claims. Among these therapy options, the most frequently utilized medication is Estradiol, which accounts for 52 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other CA PrescribersVs. CA Avg |
|---|---|---|---|
| Estradiol | 52 | $77.02 | ▲ More than typical |
About Estradiol: This medication is a hormone. Show more ▾ It is used by women to help reduce vaginal symptoms of menopause (such as vaginal dryness/burning/itching). These symptoms are caused by the body making less estrogen. When treating only vaginal symptoms of menopause, products applied directly inside the vagina (such as this medication) should be used first. Estrogens that are taken by mouth, absorbed through the skin, or injected may have greater risks of side effects due to more estrogen being absorbed. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. In 2024, this provider wrote 52 Medicare prescriptions for Estradiol, about 1.4 times the volume of the typical California prescriber of this medication (37.9). Medicare paid an average of $77.02 per fill, versus $56.87 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 138.7 30-Day Fills standardized to 30-day supplies 4,134 Days of Medication total across all patients in 2024 | |||
| Estradiol (Twice Weekly)Estradiol | 36 | $91.29▼ below CA avg | ▲ More than typical |
About Estradiol (Twice Weekly): This medication is a hormone (estrogen). Show more ▾ It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. In 2024, this provider wrote 36 Medicare prescriptions for Estradiol (Twice Weekly), about 1.3 times the volume of the typical California prescriber of this medication (26.9). Medicare paid an average of $91.29 per fill, versus $94.69 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 62.5 30-Day Fills standardized to 30-day supplies 1,834 Days of Medication total across all patients in 2024 | |||
| ProgesteroneProgesterone, Micronized | 27 | $47.05 | ≈ Typical |
About Progesterone: Progesterone is a type of hormone (progestin). Show more ▾ This medication is similar to the progesterone that your body naturally makes and is given to replace the hormone when your body is not making enough of it. In women who are not pregnant and not going through menopause, this medication is used to restore normal menstrual periods that have stopped for several months (amenorrhea). Progesterone is also used as part of combination hormone replacement therapy with estrogens to reduce menopause symptoms (such as hot flashes). Progesterone is added to estrogen replacement therapy to reduce the risk of cancer of the uterus. This medication is not for use in children. Progesterone must not be used to test for pregnancy. The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. In 2024, this provider wrote 27 Medicare prescriptions for Progesterone, about 84% of the volume of the typical California prescriber of this medication (32.2). Medicare paid an average of $47.05 per fill, versus $38.00 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 73 30-Day Fills standardized to 30-day supplies 2,190 Days of Medication total across all patients in 2024 | |||
| Estradiol (Once Weekly)Estradiol | 14 | $69.46▼ below CA avg | ▼ Less than typical |
About Estradiol (Once Weekly): This medication is a hormone (estrogen). Show more ▾ It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. In 2024, this provider wrote 14 Medicare prescriptions for Estradiol (Once Weekly), about 75% of the volume of the typical California prescriber of this medication (18.7). Medicare paid an average of $69.46 per fill, versus $77.72 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 14 30-Day Fills standardized to 30-day supplies 392 Days of Medication total across all patients in 2024 | |||
| Ibandronate Sodium | 13 | $37.46 | ▼ Less than typical |
About Ibandronate Sodium: Ibandronate is used to prevent and treat certain types of bone loss (osteoporosis). Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases after menopause, as you age, or if you take corticosteroid medications (such as prednisone) for long periods. This medication works by slowing bone loss to help maintain strong bones and reduce the risk of broken bones (fractures). Ibandronate belongs to a class of medications called bisphosphonates. Aminobisphosphonate that is a potent inhibitor of BONE RESORPTION. It is used in the treatment of HYPERCALCEMIA associated with malignancy, for the prevention of fracture and bone complications in patients with breast cancer and bone metastases, and for the treatment and prevention of POSTMENOPAUSAL OSTEOPOROSIS. In 2024, this provider wrote 13 Medicare prescriptions for Ibandronate Sodium, about half the volume of the typical California prescriber of this medication (28.4). Medicare paid an average of $37.46 per fill, versus $24.91 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34.4 30-Day Fills standardized to 30-day supplies 1,032 Days of Medication total across all patients in 2024 | |||
| PremproEstrogen,con/M-Progest Acet | 13 | $277.13▼ below CA avg | ≈ Typical |
About Prempro: This medication contains 2 hormones: an estrogen (such as conjugated estrogen, estradiol) and a progestin (such as medroxyprogesterone, norethindrone, norgestimate). Show more ▾ Some brands of this medication may contain progesterone instead of a progestin. Progesterone and progestin both act like the form of the natural hormone (progesterone) produced by your body. This medication is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. The progestin or progesterone in this medication helps to reduce the risk of cancer of the uterus which can be caused by using estrogen. Women who have had their uterus removed do not need the progestin or progesterone. They should not use this combination medication. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen/progestin treatment. Estrogen Replacement Therapy drug. In 2024, this provider wrote 13 Medicare prescriptions for Prempro, about 89% of the volume of the typical California prescriber of this medication (14.6). Medicare paid an average of $277.13 per fill, versus $317.56 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 14.8 30-Day Fills standardized to 30-day supplies 424 Days of Medication total across all patients in 2024 | |||
| YuvafemEstradiol | 13 | $148.37 | ▼ Less than typical |
About Yuvafem: This medication is a hormone (estrogen). Show more ▾ It is used by women to help reduce vaginal symptoms of menopause (such as vaginal dryness/burning/itching). These symptoms are caused by the body making less estrogen. When treating only vaginal symptoms of menopause, products applied directly inside the vagina (such as this medication) should be used first. Estrogens that are taken by mouth, absorbed through the skin, or injected may have greater risks of side effects due to more estrogen being absorbed. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. In 2024, this provider wrote 13 Medicare prescriptions for Yuvafem, about half the volume of the typical California prescriber of this medication (24.9). Medicare paid an average of $148.37 per fill, versus $137.29 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 27.4 30-Day Fills standardized to 30-day supplies 814 Days of Medication total across all patients in 2024 | |||
| Zolpidem Tartrate | 11 | $2.23▼ below CA avg | ▼ Less than typical |
About Zolpidem Tartrate: Zolpidem is used for a short time to treat a certain sleep problem (insomnia) in adults. Show more ▾ If you have trouble falling asleep, it helps you fall asleep faster, so you can get a better night's rest. Zolpidem belongs to a class of drugs called sedative-hypnotics. It acts on your brain to produce a calming effect. An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA. In 2024, this provider wrote 11 Medicare prescriptions for Zolpidem Tartrate, about a quarter of the volume of the typical California prescriber of this medication (44.7). Medicare paid an average of $2.23 per fill, versus $6.02 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for JENNIFER LAUREN BROAD M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Obstetrics & Gynecology prescribing approach at this Costa Mesa, CA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among CA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
